• Je něco špatně v tomto záznamu ?

Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement

J. Arciniega, L. Wagner, R. Prymula, P. Sebo, R. Isbrucker, B. Descampe, JM. Chapsal, A. Costanzo, C. Hendriksen, M. Hoonaker, S. Nelson, K. Lidster, W. Casey, D. Allen,

. 2016 ; 2015 (-) : 82-96. [pub] -

Jazyk angličtina Země Francie

Typ dokumentu kongresy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20014751

Grantová podpora
FD999999 Intramural FDA HHS - United States

The 'International Workshop on Alternatives to the Murine Histamine Sensitization Test for Acellular Pertussis Vaccines: Progress and Challenges in the Replacement of HIST' was held on 24 August 2014, in Prague, Czech Republic, as a satellite meeting to the 9th World Congress on Alternatives and Animal Use in the Life Sciences. Participants discussed the progress and challenges associated with the development, validation, and implementation of in vitro assays as replacements for the histamine sensitisation test (HIST) for acellular pertussis vaccines. Discussions focused on the consistency approach, the necessary framework for regulatory acceptance of a harmonised method, and recent international efforts towards the development of in vitro assays to replace the HIST. Workshop participants agreed that acceptable alternatives to the HIST should be based on ADP ribosylation-mediated cell intoxication and therefore that the CHO cell clustering assay, which measures cell intoxication, should be further pursued and developed as a possible replacement for the HIST. Participants also agreed to continue ongoing multinational discussions involving national and international standardisation authorities to reach consensus and to organise collaborative studies in this context for assay characterisation and calibration of reference materials.

000      
00000naa a2200000 a 4500
001      
bmc20014751
003      
CZ-PrNML
005      
20201012134429.0
007      
ta
008      
200922s2016 fr f 000 0|eng||
009      
AR
035    __
$a (PubMed)27506225
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Arciniega, J $u US FDA.
245    10
$a Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement / $c J. Arciniega, L. Wagner, R. Prymula, P. Sebo, R. Isbrucker, B. Descampe, JM. Chapsal, A. Costanzo, C. Hendriksen, M. Hoonaker, S. Nelson, K. Lidster, W. Casey, D. Allen,
520    9_
$a The 'International Workshop on Alternatives to the Murine Histamine Sensitization Test for Acellular Pertussis Vaccines: Progress and Challenges in the Replacement of HIST' was held on 24 August 2014, in Prague, Czech Republic, as a satellite meeting to the 9th World Congress on Alternatives and Animal Use in the Life Sciences. Participants discussed the progress and challenges associated with the development, validation, and implementation of in vitro assays as replacements for the histamine sensitisation test (HIST) for acellular pertussis vaccines. Discussions focused on the consistency approach, the necessary framework for regulatory acceptance of a harmonised method, and recent international efforts towards the development of in vitro assays to replace the HIST. Workshop participants agreed that acceptable alternatives to the HIST should be based on ADP ribosylation-mediated cell intoxication and therefore that the CHO cell clustering assay, which measures cell intoxication, should be further pursued and developed as a possible replacement for the HIST. Participants also agreed to continue ongoing multinational discussions involving national and international standardisation authorities to reach consensus and to organise collaborative studies in this context for assay characterisation and calibration of reference materials.
650    _2
$a zvířata $7 D000818
650    _2
$a CHO buňky $7 D016466
650    _2
$a křečci praví $7 D006224
650    _2
$a Cricetulus $7 D003412
650    _2
$a výchova a vzdělávání $x metody $x trendy $7 D004493
650    _2
$a histamin $x aplikace a dávkování $7 D006632
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a pertusový toxin $x terapeutické užití $7 D037342
650    _2
$a pertusová vakcína $x terapeutické užití $7 D010567
650    _2
$a acelulární vakcíny $x terapeutické užití $7 D022282
650    _2
$a pertuse $x diagnóza $x prevence a kontrola $7 D014917
651    _2
$a Česká republika $7 D018153
655    _2
$a kongresy $7 D016423
700    1_
$a Wagner, L $u US FDA.
700    1_
$a Prymula, R $u UH.
700    1_
$a Sebo, P $u ASCR.
700    1_
$a Isbrucker, R $u Health Canada.
700    1_
$a Descampe, B $u GSK.
700    1_
$a Chapsal, J M $u Sanofi Pasteur.
700    1_
$a Costanzo, A $u EDQM.
700    1_
$a Hendriksen, C $u IntraVacc.
700    1_
$a Hoonaker, M $u IntraVacc.
700    1_
$a Nelson, S $u Sanofi Pasteur.
700    1_
$a Lidster, K $u NC3Rs.
700    1_
$a Casey, W $u NIEHS.
700    1_
$a Allen, D $u ILS.
773    0_
$w MED00204613 $t Pharmeuropa bio & scientific notes $x 2075-2504 $g Roč. 2015, č. - (2016), s. 82-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27506225 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200922 $b ABA008
991    __
$a 20201012134428 $b ABA008
999    __
$a ok $b bmc $g 1571889 $s 1104911
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 2015 $c - $d 82-96 $e - $i 2075-2504 $m Pharmeuropa bio & scientific notes $n Pharmeur Bio Sci Notes $x MED00204613
GRA    __
$a FD999999 $p Intramural FDA HHS $2 United States
LZP    __
$a Pubmed-20200922

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace